Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Is ryanodine receptor phosphorylation key to the fight or flight response and heart failure?
Thomas Eschenhagen
Thomas Eschenhagen
Published November 22, 2010
Citation Information: J Clin Invest. 2010;120(12):4197-4203. https://doi.org/10.1172/JCI45251.
View: Text | PDF
Commentary Article has an altmetric score of 3

Is ryanodine receptor phosphorylation key to the fight or flight response and heart failure?

  • Text
  • PDF
Abstract

In situations of stress the heart beats faster and stronger. According to Marks and colleagues, this response is, to a large extent, the consequence of facilitated Ca2+ release from intracellular Ca2+ stores via ryanodine receptor 2 (RyR2), thought to be due to catecholamine-induced increases in RyR2 phosphorylation at serine 2808 (S2808). If catecholamine stimulation is sustained (for example, as occurs in heart failure), RyR2 becomes hyperphosphorylated and “leaky,” leading to arrhythmias and other pathology. This “leaky RyR2 hypothesis” is highly controversial. In this issue of the JCI, Marks and colleagues report on two new mouse lines with mutations in S2808 that provide strong evidence supporting their theory. Moreover, the experiments revealed an influence of redox modifications of RyR2 that may account for some discrepancies in the field.

Authors

Thomas Eschenhagen

×

Figure 1

The classical view of cardiomyocyte excitation-contraction coupling and its regulation by β-adrenergic receptors.

Options: View larger image (or click on image) Download as PowerPoint
The classical view of cardiomyocyte excitation-contraction coupling and ...
Under unstimulated conditions (black arrows), depolarization during an action potential opens LTCCs in T tubules, allowing Ca2+ to enter the cell. This trigger Ca2+ induces a larger Ca2+ release from the SR via RyR2. The increase in Ca2+ concentration initiates conformational changes of the myofilaments and thereby contraction. Removal of Ca2+ via SERCA and NCX reverses the process. Catecholamines stimulate excitation-contraction coupling (red symbols and lettering) by phosphorylating LTCCs (increased Ca2+ influx), PLB (increased Ca2+ reuptake into the SR), and myofilament-based troponin I and myosin-binding protein C (increased relaxation). AC, adenylyl cyclise; Gs, stimulatory G protein. Adapted with permission from Nature (35).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
77 readers on Mendeley
See more details